
Athena Jones
BUENOS AIRES, Argentina, June 14 (Reuters) - Genetically modified (GM)
soybean seeds have made Argentine farmer Hector Salmoiraghi's life a
lot easier, he says as he stoops to examine a soybean plant in a vast
field lined with eucalyptus trees. Salmoiraghi, whose father and
grandfather were also farmers, has been growing soybeans for 25 years,
outside the port city of San Pedro, some 124 miles (200 km) northwest
of Buenos Aires. "Genetically-modified soy simplified everything," he
said, adjusting his black gaucho-style beret and standing tall in his
rubber boots and Wrangler jeans.
Salmoiraghi began using U.S.-based biotechnology giant Monsanto's
Roundup Ready (RR) soybean seeds five years ago.Made to be resistant
to the company's powerful Roundup weed killer, the seeds cut costs by
an estimated $50-$60 per hectare (2.47 acres) by reducing the
preparation needed before planting.
Salmoiraghi, who planted 250 hectares (617.5 acres) with GM soy this
season and plans to plant more next year, says he'd never go back to
the traditional seeds: "It wouldn't make sense. GM soy is much easier
to work with."He is one of thousands of Argentine farmers singing the
praises of GM products, and now the government is behind them more
than ever before.
Argentina, a major grain and oilseed producer, is second only to the
United States in the use of biotechnology products and has recently
re-dedicated itself to promoting their development and attracting
biotech companies that want to invest here. After 3 years of a de
facto moratorium on approving GM products, Argentina in May authorized
the use of Monsanto's RR cotton. Weeks later, the government created a
biotechnology commission and Agriculture Secretary Marcelo Regunaga
set off for the United States, where he met with biotech companies and
visited research centers.
"We share the biotechnology policy of the U.S.," said Regunaga in a
recent interview. "I told (U.S. Agriculture) Secretary (Ann) Veneman
that in all the international forums, we need to present a common
position in which Argentina would have a more aggressive attitude than
it has had in the past." Argentina is betting that biotechnology is
the wave of the future. But sharing a common policy with the United
States also means the countries could share common foes.
ANTI-GM GROUPS: While proponents say GM products increase efficiency,
environmental and consumer groups say the products are not well
regulated and could contain hidden health and environmental risks. We
are against the sale of these products until there is conclusive
evidence of the long-term effects they could have," said Karla
Irigoyen, the Chile-based representative of watchdog group Consumers
International. "There is a lot of concern about the use of GM products
in Argentina, not only for the sake of Argentine consumers but also
for consumers in all of Latin America," where Argentina sends exports,
said Irigoyen.
The government is well aware that GM products are controversial and
will step up measures to ensure that no unapproved products are used
illegally and that approved products are safe, said Regunaga. Also
approved in Argentina are insect-tolerant corns made by Swiss company
Novartis and Monsanto, a herbicide-tolerant corn made by Franco-German
company Aventis and an insect-tolerant cotton made by Monsanto.
THE TRADE ISSUE: Argentina's renewed commitment to biotechnology means
that GM products are here to stay, at least for the time being. But
whether GM is the future will depend on the impact the use of these
products has on trade. Agricultural shipments make up about 60 percent
of Argentina's exports and GM products are a particularly dicey topic
in the European Union and Asia, where imports of some products have
been restricted on concern they may not be safe for human consumption.
"By approving (GM products) Argentina is definitely moving in the
wrong direction and is risking its exports," said Emiliano Ezcurra,
the coordinator of the biodiversity campaign for the Buenos Aires
office of global environmental group Greenpeace. Argentina sent nearly
30 percent of its grain exports and about 60 percent of its vegetable
oil exports to Asia in 2000, according to data from the Agriculture
Department.
China last week ruled that all production and sales of GM foods,
including imports, must have government approval certifying that they
do not cause any harm to humans, animals or the environment. It
remains to be seen how the move will affect Argentine exports.
The European Union, where Argentina shipped about 10 percent of its
grain exports and 60 percent of grain byproducts in 2000, has not
approved any new GM crop varieties since 1998. The European Parliament
in February approved strict rules to regulate GM organisms, but France
and five other countries said they would continue to block new GM
permits until further rules are put in place ensuring gene-altered
products can be traced back to their source.
"In Europe, it's a question of time," Carlos Popik, president of the
Argentine unit of Monsanto, told Reuters in a recent interview. "The
question is purely political," he said. "Europe prefers to increase
production by subsidizing it instead of making it more efficient.
These are the types of things that will be changed by time."
Regunaga seemed unconcerned about Europe: "In Europe there are people
in favor of and people against" biotechnology, he said. "Certainly, we
are going to try to find our friends in Europe so that we can have a
more aggressive international position in favor of biotechnology."
Politics aside, Argentine farmers will likely continue to support
development of GM products that cut costs. Salmoiraghi says RR soy has
helped farmers survive in San Pedro, as lower global commodity prices,
high interest rates and fuel prices and tax pressure have sent many
small producers packing. "GM soy has helped us," he said. "It hasn't
helped as much as it could have because prices have fallen, but it has
certainly helped because with these fuel prices, I'd say that even we
medium-sized producers wouldn't be around anymore."
** NOTICE: In accordance with Title 17 U.S.C. Section 107, this material is distributed for research and educational purposes only. **
|
|
|
Last Updated on 6/18/01 Email: information@biotech-info.net |
|